SCHEMBL6509391

SCHEMBL6509391

COC(=O)Oc1cccc2cc3ccccc3cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.51
HPGD P15428 5/20 0.51
HSD17B10 Q99714 3/20 0.51
ALDH1A1 P00352 6/20 0.49
GAA P10253 2/20 0.49
PGR P06401 1/20 0.49
PTGS1 P23219 1/20 0.49
MAPK1 P28482 1/20 0.49
NQO1 P15559 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
RAB9A P51151 1/20 0.41
POLB P06746 1/20 0.40
FABP7 O15540 1/20 0.40
FABP3 P05413 1/20 0.40
FABP5 Q01469 1/20 0.40
NCEH1 Q6PIU2 1/20 0.40
MTNR1A P48039 2/20 0.39
MTNR1B P49286 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28375858 0.98 KDM4E (0.50) KDM4EHPGDHSD17B10ALDH1A1GAA
SCHEMBL29591103 0.90 ALDH1A1 (0.50) KDM4EHPGDHSD17B10ALDH1A1GAA
SCHEMBL19468524 0.90 ALDH1A1 (0.50) KDM4EHPGDHSD17B10ALDH1A1GAA
SCHEMBL28339440 0.88 ALDH1A1 (0.49) KDM4EHPGDHSD17B10ALDH1A1GAA
SCHEMBL28887788 0.86 ALDH1A1 (0.42) KDM4EHPGDHSD17B10ALDH1A1GAA
SCHEMBL27792715 0.84 ALDH1A1 (0.51) KDM4EHPGDHSD17B10ALDH1A1GAA
SCHEMBL28478645 0.84 ALDH1A1 (0.41) KDM4EHPGDHSD17B10ALDH1A1GAA
SCHEMBL29525161 0.84 HSD17B10 (0.67) KDM4EHPGDHSD17B10ALDH1A1GAA
SCHEMBL1598809 0.84 HSD17B10 (0.67) KDM4EHPGDHSD17B10ALDH1A1GAA
SCHEMBL28377393 0.83 ALDH1A1 (0.53) KDM4EHPGDHSD17B10ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110891980-B Radical polymerization control agent and radical polymerization control method 川崎化成工业株式会社 2022-09-30 CN disclosed
CN-113454090-A Compound having polycyclic aromatic skeleton and endoperoxide compound thereof 川崎化成工业株式会社 2021-09-28 CN disclosed
CN-112582547-A Organic solar cell 日本瑞翁株式会社 2021-03-30 CN disclosed
CN-108884377-B Photocurable sealing agent composition, article, and organic solar cell 日本瑞翁株式会社 2021-03-19 CN disclosed
CN-108026197-B Photopolymerizable composition 川崎化成工业株式会社 2020-11-17 CN disclosed
CN-110891980-A Radical polymerization control agent and radical polymerization control method 川崎化成工业株式会社 2020-03-17 CN disclosed
US-20050269563-A1 Fullerodendrimer-comprising film ECODEVICE LABORATORY CO., LTD. (JP) 2005-12-08 US disclosed
US-20040175568-A1 Can be applied to organic semiconductor devices utilizing the optophysicochemical characteristics of fullerene, and in particular, to solar panel materials, organic EL materials, photorefractive polymers, electrophotographic light-sensitive materials, film materials having environmental cleansing actions ECODEVICE LABORATORY CO., LTD. (JP) 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050269563-A1 Fullerodendrimer-comprising film TOMM70, SCO2, S100A10 KDM4E 3831/4885HPGD 2464/4885HSD17B10 574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.